Plain-English translation of NCT02038660 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is following patients who have received treatment with a drug-eluting balloon—a specialized balloon coated with medication that helps prevent blood vessels from narrowing again after being opened. Researchers want to understand how well and how safely this treatment works in real-world clinical practice over the long term. You would be part of a registry that tracks your health outcomes after receiving this treatment.
While this medication has been studied in controlled trials, doctors need to understand how it performs when used in everyday practice across different hospitals and patient populations. This real-world data helps ensure the treatment is safe and effective for patients like you.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive the drug-coated balloon treatment as part of your normal medical care, and then the research team would follow your health over time through scheduled visits and check-ups. They will collect information about how you are doing, any symptoms you experience, and any additional medical events. Your participation helps doctors learn whether this treatment continues to work safely and effectively for patients in real-world settings.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
South Korea